The evolution of the PCPT from clinical to molecular analyses

Ashraful Hoque

doi:10.1038/ncponc0653 | Full Text | PDF (76K)

Radiotherapy alone is suitable in older patients with early-stage Hodgkin lymphoma

doi:10.1038/ncponc0601 | Full Text | PDF (87K)

Gene expression profiles for renal cell carcinoma and renal regeneration show similarity

doi:10.1038/ncponc0613 | Full Text | PDF (87K)

Anastrozole preferred to tamoxifen for treatment of early-stage breast cancer

doi:10.1038/ncponc0614 | Full Text | PDF (95K)

Comparison of fluorouracil regimens after surgery for rectal cancer

doi:10.1038/ncponc0615 | Full Text | PDF (88K)

Comparing LTA with TH for the treatment of gastric cancer

doi:10.1038/ncponc0616 | Full Text | PDF (95K)

Micrometastases predict relapse and survival in high-risk breast cancer

doi:10.1038/ncponc0618 | Full Text | PDF (87K)

Correlation between physical activity, colorectal cancer and survival

doi:10.1038/ncponc0620 | Full Text | PDF (95K)

RT-PCR assay shows potential for detecting micrometastases in colorectal cancer

doi:10.1038/ncponc0623 | Full Text | PDF (88K)

CAD improves cancer detection in screening and diagnostic mammograms

doi:10.1038/ncponc0624 | Full Text | PDF (95K)

Local recurrence reduced in young women with DCIS treated with boost radiotherapy

doi:10.1038/ncponc0625 | Full Text | PDF (87K)

Gene-expression-based models: high concordance in outcome prediction for breast cancer

doi:10.1038/ncponc0626 | Full Text | PDF (96K)

Calculating the risk of toxicity for patients with advanced GIST treated with imatinib

doi:10.1038/ncponc0628 | Full Text | PDF (89K)

New European guidelines for the use of G-CSF for chemotherapy-induced neutropenia

doi:10.1038/ncponc0629 | Full Text | PDF (89K)

Can thalidomide improve outcome in patients with multiple myeloma?

Paul G Richardson, Constantine S Mitsiades, Nikhil C Munshi and Kenneth C Anderson

doi:10.1038/ncponc0630 | Full Text | PDF (100K)

Poor correlation between physician and patient assessment of quality of life in palliative care

Eduardo Bruera

doi:10.1038/ncponc0635 | Full Text | PDF (97K)

Rituximab and CHOP-like chemotherapy in good-prognosis diffuse large-B-cell lymphoma

Bertrand Coiffier

doi:10.1038/ncponc0638 | Full Text | PDF (97K)

Can the utility of secondary cytoreduction for ovarian cancer be reliably established?

Linda Duska

doi:10.1038/ncponc0659 | Full Text | PDF (98K)

Focusing on physical function limitations in elderly women surviving cancer: any opportunity for improvement?

Silvia Dellapasqua, Marco Colleoni and Aron Goldhirsch

doi:10.1038/ncponc0633 | Full Text | PDF (99K)

Does tumor mutational status correlate with clinical response to imatinib?

Michael C Heinrich and Christopher L Corless

doi:10.1038/ncponc0639 | Full Text | PDF (100K)

Stabilization of disease in patients with metastatic renal cell carcinoma using sorafenib

Brian I Rini

doi:10.1038/ncponc0634 | Full Text | PDF (99K)

Ovarian cancer: a focus on management of recurrent disease

Thomas J Herzog and Bhavana Pothuri

doi:10.1038/ncponc0637 | Full Text | PDF (162K)

Stress and breast cancer: a systematic update on the current knowledge

Naja Rod Nielsen and Morten Grønbæk

doi:10.1038/ncponc0652 | Full Text | PDF (196K)